Tongji-Ezhou Study
TJEZ
Tongji-Ezhou Prospectively Cohort Study
1 other identifier
observational
10,000
1 country
1
Brief Summary
Tongji-Ezhou study (TJEZ) is a prospective cohort study launched at 2013 in EZhou city, Hubei province, with the goal of recruiting and assessing 10,000 individuals and then following them for at least 2 decades. In addition, blood samples would be collected every 3-5 years among 6000 of them to investigate the nutritional biomarkers and potential determinants of chronic diseases such as obesity, type 2 diabetes, metabolic syndrome, and cardiovascular disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 16, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2019
CompletedFirst Submitted
Initial submission to the registry
February 14, 2019
CompletedFirst Posted
Study publicly available on registry
February 19, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFebruary 19, 2019
February 1, 2019
5.8 years
February 14, 2019
February 16, 2019
Conditions
Outcome Measures
Primary Outcomes (4)
Incidence of diabetes
Type 2 diabetes was diagnosed when FPG ≥ 7.0 mmol/L and/or OGTT2h ≥ 11.1 mmol/L, or using diabetic medication (self-report).
5 years
Incidence of metabolic syndrome
Metabolic syndrome is defined as using the updated National Cholesterol Education Program/Adult Treatment Panel III criteria for Asian Americans. These criteria require three or more of the following components: (1) central obesity (waist circumference of ≥90 cm for men or ≥80 cm for women), (2) triglycerides of ≥1.7 mmol/L, (3) HDL-C of \<1.03 mmol/L for men or \<1.30 mmol/L for women, (4) blood pressure of ≥130/85 mmHg or on medication for hypertension, and (5) fasting glucose of ≥5.6 mmol/L.
5 years
Diabetic complications
Development of diabetic complications
mean follow up of 10 years
Incidence of cardiovascular diseases
Cardiovascular death, stroke, myocardial infarction, heart failure
mean follow up of 10 years
Study Arms (2)
Egang hospital physical examination center
Ezhou CDC physical examination center
Interventions
Eligibility Criteria
Samples were collected at two medical centrals (retired employees at Egang hospital and working employees at Ezhou CDC). The Retirement Office of Egang hospital and Health checkup center of CDC provided a list of the individuals and invited them to participant in our study.
You may qualify if:
- (i) permanent residence in Ezhou district (minimum of 9 months); (ii) written informed consent; (iii) age ≥ 20 years old at the time of enrolling in the study.
You may not qualify if:
- (i) with chemotherapy or radiotherapy for cancer and other severe diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
Related Publications (1)
Sun T, Deng Y, Geng X, Fang Q, Li X, Chen L, Zhan M, Li D, Zhu K, Li H, Liu L. Plasma Alkylresorcinol Metabolite, a Biomarker for Whole-Grain Intake, Is Inversely Associated with Risk of Nonalcoholic Fatty Liver Disease in a Case-Control Study of Chinese Adults. J Nutr. 2022 Apr 1;152(4):1052-1058. doi: 10.1093/jn/nxab404.
PMID: 35091747DERIVED
Biospecimen
Blood, urine, and DNA were collected by clinicians during the morning after the examinees. Blood samples (5 ml) are collected with ethylenediamine tetra acetic acid anticoagulant tube from peripheral vessels. Plasma, buffy coat, and red blood cell layer are separated. The samples are stored at -80°C for future analyses. All bio-samples will be tracked through an electronic database.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice dean of School of Public Health, Tongji Medical College
Study Record Dates
First Submitted
February 14, 2019
First Posted
February 19, 2019
Study Start
April 16, 2013
Primary Completion
January 31, 2019
Study Completion
December 31, 2025
Last Updated
February 19, 2019
Record last verified: 2019-02